# Self-invented Intracavitary ECG Wire VS the Commercial System - Certodyn®

> **NCT03697291** · NA · UNKNOWN · sponsor: **Mahidol University** · enrollment: 36 (estimated)

## Conditions studied

- Central Line Complication

## Interventions

- **DEVICE:** PS wire

## Key facts

- **NCT ID:** NCT03697291
- **Lead sponsor:** Mahidol University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-08-01
- **Primary completion:** 2019-06-30
- **Final completion:** 2019-10-31
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2018-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03697291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03697291, "Self-invented Intracavitary ECG Wire VS the Commercial System - Certodyn®". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03697291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*